We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026

Hospital-Acquired Infections Diagnostics Market Growing Rapidly

By HospiMedica International staff writers
Posted on 18 Sep 2012
The growing focus on hospital-acquired infections (HAI) as a driver of costs and negative outcomes is increasing demand for diagnostic products that can help hospitals and nursing homes decide which patients need treatment and possible isolation. More...
These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

With 5% of the nearly 40 million hospital visits a year in the United States resulting in a HAI, nearly 100,000 people die each year from nosocomial infections, a fifth of these from methicillin-resistant Staphylococcus aureus (MRSA) alone. According to the report, the most common HAIs--also known as nosocomial infections--include MRSA, tuberculosis, and urinary tract infections. In the intensive care unit (ICU), where infection is most harmful due to the compromised status of patients, community-acquired pneumonia (CAP) is a growing problem.

The need to combat HAIs has led to increased sales of in vitro diagnostic (IVD) products designed to test for these infections, a market, which grew by 10% in 2011 alone, reaching a value of USD 1.2 billion. The simplest tests consist of a nostril swab to detect MRSA and assist in admissions screening to reduce the spread of the disease. Specific to tuberculosis, identifying the M. tuberculosis organism is necessary for diagnosis, and methods include imaging or the Mantoux skin test. More complicated testing areas including drug resistance and susceptibility testing, DNA sequencing, solid-phase hybridization, microarrays, phage-based assays, and many more.

“Nosocomial infections are a fact of life in healthcare right now; as one infection may decline, a new infection appears, or there is an increase in the incidence of another,” said Bruce Carlson, publisher of Kalorama Information. “Speed is essential in identifying these infections, and there are a host of tests out there, targeting specific infections, and offering fast results.”

Nosocomial infections are commonly transmitted when hospital officials become complacent and personnel do not practice correct hygiene regularly. Also, increased use of outpatient treatment means people who are hospitalized are more ill and have more weakened immune systems than may have been true in the past. Moreover, some medical procedures bypass the body's natural protective barriers. Additionally, since medical staff circulates from patient to patient, the staff itself often serves as vectors for spreading pathogens.

Related Links:
Kalorama Information


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hypodermic Syringe
SurTract™ Safety Syringe
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.